Semaglutide is sold under three brand names, each with slightly different dosing profiles: Ozempic injectable, once-weekly, approved for type 2 diabetes and cardiovascular risk reduction Wegovy injectable, once-weekly, higher dose (up to 2.4 mg), approved for weight management Rybelsus oral tablet, taken daily, approved for type 2 diabetes All three share the same active ingredient and similar side-effect profiles, though Wegovy at higher doses tends to cause more frequent GI symptoms
"I started taking it straight away, and it really affected me
Surg Obes Relat Dis 18(9):11091119 McGlone ER, Carey I, Velikovi V, Chana P, Mahawar K, Batterham RL et al (2020) Bariatric surgery for patients with type 2 diabetes mellitus requiring insulin: clinical outcome and cost-effectiveness analyses
Discover personalized care designed to transform your weight loss journey with lastingsustainable results!
2026 Semaglutide Pricing Context In November 2025, the Trump administration announced a negotiated price agreement capping Wegovy and Ozempic at $245 per month through TrumpRx less than half of prior market prices